[{"id":"63510f70-5f36-4b34-ad53-482142faa7dd","acronym":"","url":"https://clinicaltrials.gov/study/NCT05397093","created_at":"2022-05-31T12:54:49.543Z","updated_at":"2024-07-02T16:35:16.459Z","phase":"Phase 1","brief_title":"ITIL-306 in Advanced Solid Tumors","source_id_and_acronym":"NCT05397093","lead_sponsor":"Instil Bio","biomarkers":" EGFR • KRAS • ALK • BRCA","pipe":" | ","alterations":" BRCA mutation","tags":["EGFR • KRAS • ALK • BRCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • ITIL-306"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 51","initiation":"Initiation: 08/24/2022","start_date":" 08/24/2022","primary_txt":" Primary completion: 07/01/2025","primary_completion_date":" 07/01/2025","study_txt":" Completion: 11/01/2039","study_completion_date":" 11/01/2039","last_update_posted":"2024-03-05"}]